SRPT FY 2020 Earnings — Sarepta Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

SRPTSarepta Therapeutics, Inc.

$2B

FY 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$540M+41.8% YoY

Gross Profit

$477M88.3% margin

Operating Income

-$564M-104.5% margin

Net Income

-$554M-102.6% margin

EPS (Diluted)

$-7.11

Cash Flow

Operating Cash Flow

$107M

Free Cash Flow

$25M

Stock-Based Comp.

$108M

Balance Sheet

Total Assets

$3.0B

Total Liabilities

$2.2B

Stockholders' Equity

$762M

Cash & Equivalents

$1.5B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$540M	$381M	+41.8%
Gross Profit	$477M	$324M	+47.0%
Operating Income	-$564M	-$706M	+20.0%
Net Income	-$554M	-$715M	+22.5%